You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 8, August 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL APPLICATIONS OF THERAPEUTIC ADVANCES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nonsteroidal Anti-inflammatory Drugs

Robert E. Wolf, MD, PhD

Arch Intern Med. 1984;144(8):1658-1660.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Over the past decade, many new nonsalicylate, nonsteroidal anti-inflammatory drugs (NSAIDs) have been introduced in the United States. These include fenoprofen, ibuprofen, meclofenamate, naproxen, piroxicam, sulindac, and tolmetin in addition to indomethacin and phenylbutazone, which were previously available. These drugs have added to our therapeutic armamentarium for management of degenerative joint disease (DJD) and rheumatoid arthritis (RA) as well as other rheumatic and nonrheumatic disorders.

CLASSIFICATION AND CLINICAL PHARMACOLOGY

Figure 1 provides a chemical classification of currently available NSAIDs. Although these groupings do not hold notable clinical relevance, differences among the classes may be unveiled as we gain more understanding of their pharmacologic activity.

All NSAIDs are rapidly absorbed and highly protein bound with peak serum levels occurring within four hours after ingestion. Half-life varies from two to 50 hours with excretion via urine, bile, and feces as inactive metabolites, with less than 10% excreted unchanged. At pharmacologic doses, NSAIDs . . . [Full Text PDF of this Article]


Author Affiliations

From the Section of Rheumatology, the Department of Medicine, Louisiana State University Medical Center, Shreveport.


Footnotes

Accepted for publication Jan 22,1984.

Reprint requests to Section of Rheumatology, Department of Medicine, PO Box 33932, Louisiana State University Medical Center, Shreveport, LA 71130 (Dr Wolf).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.